ZyVersa Therapeutics Stock (NASDAQ: ZVSA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 830.000 / 204.285K |
Day Range | - - - |
52 Wk Range | 3.940 - 283.780 |
Market Cap | $3.999M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 1.78% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ZyVersa Therapeutics (NASDAQ: ZVSA) through any online brokerage.
Other companies in ZyVersa Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).
The latest price target for ZyVersa Therapeutics (NASDAQ: ZVSA) was reported by HC Wainwright & Co. on Tuesday, March 26, 2024. The analyst firm set a price target for 12.00 expecting ZVSA to rise to within 12 months (a possible 150.52% upside). 4 analyst firms have reported ratings in the last year.
The stock price for ZyVersa Therapeutics (NASDAQ: ZVSA) is $4.79 last updated Today at June 10, 2024 at 7:00 AM EDT.
There are no upcoming dividends for ZyVersa Therapeutics.
ZyVersa Therapeutics’s Q2 earnings are confirmed for Monday, August 19, 2024.
There is no upcoming split for ZyVersa Therapeutics.
ZyVersa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.